Efavirenz Dissolution Enhancement I: Co-Micronization

Efavirenz Dissolution Enhancement I: Co-Micronization

AIDS constitutes one of the most serious infectious diseases, representing a major public health priority. Efavirenz (EFV), one of the most widely used drugs for this pathology, belongs to the Class II of the Biopharmaceutics Classification System for drugs with very poor water solubility. To improv...

Full description

Bibliographic Details
Main Authors:	Helvécio Vinícius Antunes Rocha, Cristiane Rodrigues Drago Hoffmeister, Rafael Cardoso Seiceira, Carlos Rangel Rodrigues, Maíra Assis da Costa, Lucio Mendes Cabral
Format:	Article
Language:	English
Published:	MDPI AG 2012-12-01
Series:	Pharmaceutics
Subjects:	efavirenz dissolution micronization poorly soluble drugs sodium lauryl sulfate polyvinylpyrrolidone
Online Access:	http://www.mdpi.com/1999-4923/5/1/1

Similar Items

Micronization for Enhancement of Curcumin Dissolution via Electrospraying Technique
by: Kimthet Chhouk, et al.
Published: (2018-12-01)

Efavirenz dissolution enhancement V - A combined top down/bottom up approach on nanocrystals formulation
by: Gabriela Julianelly Sartori, et al.
Published: (2022-04-01)

Dissolution Kinetics of Meloxicam Formulations Co-Milled with Sodium Lauryl Sulfate
by: Jan Patera, et al.
Published: (2022-10-01)

Modeling of the Aqueous Solubility of N-butyl-N-methyl-1-phenylpyrrolo[1,2-a] pyrazine-3-carboxamide: From Micronization to Creation of Amorphous–Crystalline Composites with a Polymer
by: Vladimir B. Markeev, et al.
Published: (2023-10-01)

Morphological Effects of Au Nanoparticles on Electrochemical Sensing Platforms for Nitrite Detection
by: Ruiqin Feng, et al.
Published: (2023-06-01)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz
by: Manoranjenni Chetty, et al.
Published: (2018-03-01)

Influence of the Efavirenz Micronization on Tableting and Dissolution
by: Lucio Mendes Cabral, et al.
Published: (2012-09-01)

Preparation, characterization, dissolution, and permeation of flibanserin − 2-HP-β-cyclodextrin inclusion complexes
by: Adel F. Alghaith, et al.
Published: (2021-09-01)

Efavirenz and neuropsychiatric effects
by: Mukesh Dheda
Published: (2017-04-01)

Physicochemical characterisation of spray dried ternary solid dispersions of simvastatin. Processability, tableting and dissolution
by: Hanan Abdalmaula, et al.
Published: (2019-04-01)

Rapid and sensitive quantification of efavirenz in rat plasma using HPLC-MS/MS method
by: Leandro Tasso, et al.
Published: (2024-01-01)

KANDUNGAN SODIUM LAURYL SULFATE PADA PASTA GIGI SERTA KAITANNYA DENGAN pH SALIVA DAN TINGKAT KEMATANGAN PLAK (Tinjauan Pustaka)
by: Yufitri Mayasari, et al.
Published: (2021-02-01)

TOPOGRAFI DENTIN SETELAH PENYIKATAN DENGAN SODIUM LAURYL SULFATE PADA BERBAGAI DURASI WAKTU DITINJAU DENGAN ATOMIC FORCE MICROSCOPY
by: Abdillah Imron Nasution, et al.
Published: (2018-06-01)

Recrystallization of Commercial Carbamazepine Samples—A Strategy to Control Dissolution Variability
by: Felicia Flicker, et al.
Published: (2012-01-01)

Influence of milling process on efavirenz solubility
by: Erizal Zaini, et al.
Published: (2017-01-01)

A Case Series of Efavirenz Induced Gynaecomastia
by: Charu Jain , Neha Sharma , Uma Advani , Lokendra Sharma , Munesh Kumar , Monica Jain
Published: (2023-08-01)

Physicochemical Properties and In Vitro Dissolution of Spiramycin Microparticles Using the Homogenate-Antisolvent Precipitation Process
by: Xiaonan Zhang, et al.
Published: (2016-12-01)

Safety, strength and simplicity of efavirenz in pregnancy
by: Prinitha Pillay, et al.
Published: (2012-03-01)

Role of Surfactant Micellization for Enhanced Dissolution of Poorly Water-Soluble Cilostazol Using Poloxamer 407-Based Solid Dispersion via the Anti-Solvent Method
by: Gang Jin, et al.
Published: (2021-05-01)

Comparative evaluation of antibacterial property and substantivity of chlorhexidine containing dentifrices with sodium lauryl sulfate and Tween as surfactants: An in vivo study
by: V Venu, et al.
Published: (2013-01-01)

Como pesquisar o perfil patentário de um fármaco: o caso Efavirenz How to determine the patent profile of a drug: a case study of Efavirenz
by: Jaqueline Mendes Soares, et al.
Published: (2010-01-01)

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
by: Selemani Saidi Sungi, et al.
Published: (2018-10-01)

Efavirenz: History, Development and Future
by: Bárbara Costa, et al.
Published: (2022-12-01)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
by: Thandekile C. Manzini, et al.
Published: (2016-12-01)

Development and validation of a HPLC analytical assay method for efavirenz tablets: a medicine for HIV infections
by: Osnir de Sá Viana, et al.
Published: (2011-03-01)

The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam
by: Csilla Bartos, et al.
Published: (2016-04-01)

Rheological characterisation of chitosan/sodium lauryl ether sulfate complexes
by: Milinković-Budinčić Jelena R., et al.
Published: (2019-01-01)

Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe
by: Sandra Shawarira-Bote, et al.
Published: (2019-08-01)

7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-Dihydroxy Metabolite
by: Natalia Mast, et al.
Published: (2024-02-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny
Published: (2009-12-01)

Pharmacokinetic interactions between rifampicin and efavirenz in HIV-TB coinfections
by: Yenny Yenny
Published: (2016-02-01)

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis
by: Nathan W. Cummins, et al.
Published: (2015-07-01)

Pharmacokinetics of Efavirenz 600mg in Combination with Rifampicin in Chinese HIV/TB Co-Infection Patients
by: Wang T, et al.
Published: (2023-07-01)

Design and Performance Analysis of a Sub-micron Piezoelectric Flexible Micro Drive System
by: Zhang Chuanwei, et al.
Published: (2020-01-01)

Development and validation of analytical method for quantitation of Emtricitabine, Tenofovir, Efavirenz based on HPLC
by: Arun Ramaswamy, et al.
Published: (2018-02-01)

Efavirenz poisoning in a 12 year old HIV negative African boy
by: Rose Nazziwa, et al.
Published: (2012-07-01)

Perspectives of healthcare professionals of the neuropsychiatric side effects associated with efavirenz and its management
by: Razia Gaida, et al.
Published: (2018-10-01)

Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach
by: Bhola Jaydip, et al.
Published: (2020-06-01)

Development of reverse phase high-performance liquid chromatographic method for the estimation of HIV non-nucleoside reverse transcriptase inhibitor drug efavirenz in the rat brain
by: Smita Prakash Kakad, et al.
Published: (2021-01-01)

FDA Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses In Vitro
by: Michal Stefanik, et al.
Published: (2020-06-01)